PROFILE OF PEDIATRIC CHRONIC MYELOID LEUKEMIA IN THE ERA OF IMATINIB-A STUDY FROM A DEVELOPING COUNTRY

被引：0
|
作者：
Bernard, Catherene [1 ]
Rajendran, Rashmika [1 ]
Suman, Febe Renjitha [1 ]
Scott, Julius Xavier [1 ]
Rajendran, Aruna [1 ]
机构：
[1] Sri Ramachandra Med Coll & Res Inst, Madras, Tamil Nadu, India
来源：
PEDIATRIC BLOOD & CANCER | 2016年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
514
引用
收藏
页码：S17 / S18
页数：2
相关论文
共 50 条
  • [21] Cytogenetic studies on a chronic myeloid leukemia case developing into acute myeloid leukemia after treatment with imatinib
    Kroes, Wilma
    den Ouden, Elke
    Kok, Edwin
    Kerkhoffs, Jean Louis
    CHROMOSOME RESEARCH, 2013, 21 : S85 - S85
  • [22] Treatment of chronic myeloid leukemia with imatinib: IRIS study
    Saußele S.
    Nitschmann S.
    Der Internist, 2017, 58 (11): : 1220 - 1221
  • [23] An anthropometric study in children with chronic myeloid leukemia on imatinib
    Goteke, Vamshi Krishna Reddy
    Maddi, Rahul Narayan
    Thota, Narender Kumar
    Coca, Pragnya
    Nagalla, Balakrishna
    Linga, Vijay Gandhi
    Gundeti, Sadashivudu
    Digumarti, Raghunadharao
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [24] Pattern of Pediatric Chronic Myeloid Leukemia in Sudan and Hematological Response to Imatinib
    Alkhatib, Mohammed Awad
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2011, 28 (02) : 100 - 105
  • [25] Response dynamics of pediatric patients with chronic myeloid leukemia on imatinib therapy
    Proschmann, Rick
    Baldow, Christoph
    Rothe, Tino
    Suttorp, Meinolf
    Thiede, Christian
    Tauer, Josephine T.
    Mfiller, Martin C.
    Hochhaus, Andreas
    Roeder, Ingo
    Glauche, Ingmar
    HAEMATOLOGICA, 2017, 102 (02) : E39 - E42
  • [26] Imatinib mesylate, a new drug for chronic myeloid leukemia in pediatric patients
    Thavaraj, Vasantha
    Seth, Rachna
    WORLD JOURNAL OF PEDIATRICS, 2007, 3 (02) : 110 - 114
  • [27] Imatinib in pediatric chronic myeloid leukemia patients - An India experience.
    Suresh, Attili
    Appaji, L.
    Bapsy, P. P.
    Kumari, B. S. Aruna
    Govindbabu, K.
    Lokanatha, Dasappa
    Anupama, G.
    Suresh, Attili
    PEDIATRIC BLOOD & CANCER, 2007, 49 (04) : 466 - 466
  • [28] Response assessment of patients with chronic myeloid leukemia receiving imatinib mesylate (Glivec) therapy: experience from a single center in a developing country
    Medhi, Kunjahari
    Raina, Vinod
    Kumar, Lalit
    Sharma, Atul
    Bakhshi, Sameer
    Gupta, Ritu
    Kumar, Rajive
    LEUKEMIA & LYMPHOMA, 2010, 51 (10) : 1850 - 1854
  • [29] Molecular resistance to imatinib in chronic myeloid leukemia. From the Italian Cooperative Study Group on chronic myeloid leukemia.
    Martinelli, G
    Soverini, S
    Rosti, G
    Bassi, S
    Amabile, M
    Trabacchi, E
    Giannini, B
    Cilloni, D
    Izzo, B
    de Vivo, A
    Testoni, N
    Cambrin, GR
    Bonifazi, F
    Luatti, S
    Gottardi, E
    Alberti, D
    Pane, F
    Salvatore, F
    Saglio, G
    Baccarani, M
    BLOOD, 2003, 102 (11) : 312B - 312B
  • [30] Chronic Myeloid Leukemia: Long-Term Outcome Data in the Imatinib Era
    Prasanth Ganesan
    Trivadi S. Ganesan
    Venkatraman Radhakrishnan
    Tenali Gnana Sagar
    Krishnarathinam Kannan
    Manikandan Dhanushkodi
    Jayachandran Perumal Kalayarasi
    Nikita Mehra
    Indian Journal of Hematology and Blood Transfusion, 2019, 35 : 37 - 42
12345